🇺🇸 FDA
Patent

US 7399759

1, 3-benzothiazinone derivatives and use thereof

granted A61KA61K31/5415A61P

Quick answer

US patent 7399759 (1, 3-benzothiazinone derivatives and use thereof) held by Takeda Pharmaceutical Company Limited expires Mon Jul 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Jul 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/5415, A61P, A61P1/00, A61P13/12